Community weight loss program shows promise for older black women
NCT ID NCT03843190
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a 6-month peer-led weight loss program called TOPS (Take Off Pounds Sensibly) in 116 older African American women with obesity. Participants attended dietitian-facilitated classes, while a waitlist group received the program later. The goal was to see if this community-based approach could help them lose weight and improve physical function, potentially lowering heart disease risk and boosting quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Take of Pounds Sensibly (TOPS) peer-led weight loss program
- What this could lead to
- If successful, this program could help older African American women lose weight and improve their physical function, reducing risks for heart disease and other obesity-related conditions.
- What could go wrong
- This is a small, completed feasibility study with 116 participants. Results may not apply to other groups, and weight loss programs often have mixed long-term success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
116 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 99 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * African American women aged ≥55 * BMI ≥27 kg/m2 * Stable body weight (± 2 kg for 6 months prior to study) * Sedentary (not exercising more than 1 hour per week) * Must have a primary care provider and provide contact information Conditional Inclusion Criteria: Participants with type 2 diabetes on insulin or sulfonylureas will be allowed to participate in the study only if their providers agree to manage the changing medications requirements associated with possible weight loss by signing a "Permission to Participate" form. It is important to include patients with type 2 diabetes on insulin and sulfonylureas because these participants can benefit greatly from weight loss. Exclusion Criteria: * Type 2 diabetes on insulin or sulfonylureas without provider approval * current cancer diagnosis * Provider did not approve participation * use of medications thought to effect metabolism, body weight, energy expenditure, or appetite * major psychiatric disorder * current moderate to severe symptoms of depression * dementia * neurological conditions causing functional limitations * unstable medical illness such as unstable angina, recent MI, or congestive heart failure class III-IV * terminal medical conditions * Currently enrolled in a weight loss program
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
Durham, North Carolina, 27707, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?